
Share
An AI-driven tool aims to empower policymakers in low-to-middle-income countries to develop more effective strategies against antimicrobial resistance, potentially saving lives threatened by drug-resistant infections.
Antimicrobial resistance (AMR) is a growing global health threat that makes common infections harder to treat, leading to increased illness and death. This issue disproportionately affects low-to-middle-income countries where poor water quality and environmental conditions can exacerbate the spread of resistant microorganisms. To combat this, an international team of researchers has developed an AI tool designed to support policymakers in creating effective National Action Plans (NAPs) against AMR.
AMR occurs when bacteria, viruses, and other microorganisms evolve to resist the drugs used to treat them. This resistance can turn once-manageable infections into life-threatening conditions. Diseases like HIV, tuberculosis, and malaria become more difficult to control, putting millions at risk, particularly in regions with limited healthcare resources.
In 2015, the World Health Organization (WHO) launched a Global Action Plan to coordinate efforts against AMR. As part of this initiative, 194 WHO member states committed to developing country-specific One Health AMR National Action Plans. The One Health model emphasizes the interconnectedness between human, animal, and environmental health, recognizing that solutions must address all these areas.
Despite the global commitment, many low-to-middle-income countries face significant hurdles in implementing NAPs. These challenges include inadequate logistical capacity, funding constraints, and limited access to essential information. Without robust data and support, policymakers struggle to make informed decisions that effectively combat AMR.
To address these gaps, researchers from the Chinese Academy of Sciences and Durham University in the UK have developed an AI tool called AMR-Policy GPT. This large language model is specifically designed to assist in the creation of NAPs by providing policymakers with accurate, up-to-date information on AMR.
AMR-Policy GPT contains data from 146 countries, drawing on a wide range of AMR-related policy documents. The tool functions similarly to popular AI chatbots like ChatGPT but is tailored to offer more contextually relevant and current information about AMR. This focused approach ensures that policymakers receive the most accurate and useful data to inform their decisions.

Professor David Graham from Durham University’s Department of Biosciences explains, "Our prototype is a valuable starting point for National Action Plans, especially in regions lacking local data or infrastructure. The tool provides decision-makers with well-referenced information from all relevant disciplines at their fingertips."
The AMR-Policy GPT is designed to be an intelligent information source, not a comprehensive policy writer. It acts like having a knowledgeable advisor in the room, offering insights and references that can guide policymakers through the complex process of developing effective NAPs.
The researchers are committed to continuously updating the tool to ensure it remains current and effective. They plan to gather feedback from users to identify areas for improvement and expansion. In the future, they aim to integrate even more scientific knowledge into the platform.
Professor Yong-Guan Zhu from the Chinese Academy of Sciences adds, "We believe this tool will help bridge critical knowledge gaps and support a holistic approach to combating AMR. By increasing knowledge-sharing across countries, we can better address the environmental spread of resistant microorganisms."
The development of AMR-Policy GPT marks a significant step forward in the global fight against antimicrobial resistance. By providing policymakers with the information they need to make informed decisions, this AI tool has the potential to strengthen national and international efforts to protect public health.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
23 January 2025
88 articles
Related Articles
Related Articles
More Stories